Revefenacin is a synthetic anticholinergic agent that is used as a once daily, nebulized inhalant for maintenance treatment of patients with chronic obstructive pulmonary disease. Revefenacin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury. It is grouped under the following drug class(es): Anticholinergics and Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Yupelri, revefenacinum and TD-4208. Its PubChem CID is 11753673.
Revefenacin
| CAS No | 864750-70-9 |
|---|---|
| Molecular Formula | C35H43N5O4 |
| Molecular Weight | 597.7 g/mol |
| Synonyms | [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Revefenacin is a synthetic anticholinergic agent that is used as a once daily, nebulized inhalant for maintenance treatment of patients with chronic obstructive pulmonary disease.
The listed CAS number is 864750-70-9.
The listed molecular formula is C35H43N5O4.
The listed molecular weight is 597.7 g/mol.
[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate.
The source lists Yupelri, revefenacinum and TD-4208.